Aflibercept Dose in Polypoidal Choroidal Vasculopathy

Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content:

• Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy